Related references
Note: Only part of the references are listed.Prostate Cancer Early Detection, Version 2.2016
Peter R. Carroll et al.
JOURNAL OF THE NATIONAL COMPREHENSIVE CANCER NETWORK (2016)
Six Weeks of Fluoroquinolone Antibiotic Therapy for Patients With Elevated Serum Prostate-specific Antigen Is Not Clinically Beneficial: A Randomized Controlled Clinical Trial
Alyssa Greiman et al.
UROLOGY (2016)
Eviprostat has an identical effect compared to pollen extract (Cernilton) in patients with chronic prostatitis/chronic pelvic pain syndrome: a randomized, prospective study
Hiromichi Iwamura et al.
BMC UROLOGY (2015)
Infectious Complications Following Transrectal Ultrasound-Guided Prostate Biopsy: New Challenges in the Era of Multidrug-Resistant Escherichia coli
Deborah A. Williamson et al.
CLINICAL INFECTIOUS DISEASES (2013)
Systematic Review of Complications of Prostate Biopsy
Stacy Loeb et al.
EUROPEAN UROLOGY (2013)
Increasing Hospital Admission Rates for Urological Complications After Transrectal Ultrasound Guided Prostate Biopsy
Robert K. Nam et al.
JOURNAL OF UROLOGY (2013)
Fluoroquinolone-resistant acute prostatitis requiring hospitalization after transrectal prostate biopsy: effect of previous fluoroquinolone use as prophylaxis or long-term treatment
Sinan Ekici et al.
INTERNATIONAL UROLOGY AND NEPHROLOGY (2012)
Antibiotics and observation have a similar impact on asymptomatic patients with a raised PSA
Flavio L. Heldwein et al.
BJU INTERNATIONAL (2011)
Long-term Fluoroquinolone Use Before the Prostate Biopsy May Increase the Risk of Sepsis Caused by Resistant Microorganisms
Bulent Akduman et al.
UROLOGY (2011)
A Risk-Based Strategy Improves Prostate-Specific Antigen-Driven Detection of Prostate Cancer
Monique J. Roobol et al.
EUROPEAN UROLOGY (2010)
A Pollen Extract (Cernilton) in Patients with Inflammatory Chronic Prostatitis-Chronic Pelvic Pain Syndrome: A Multicentre, Randomised, Prospective, Double-Blind, Placebo-Controlled Phase 3 Study
Florian M. E. Wagenlehner et al.
EUROPEAN UROLOGY (2009)
Systematic Review of Pretreatment Prostate-Specific Antigen Velocity and Doubling Time As Predictors for Prostate Cancer
Andrew J. Vickers et al.
JOURNAL OF CLINICAL ONCOLOGY (2009)
Screening and Prostate-Cancer Mortality in a Randomized European Study
Fritz H. Schroeder et al.
NEW ENGLAND JOURNAL OF MEDICINE (2009)
PSA Levels of 4.0-10 ng/ml and Negative Digital Rectal Examination. Antibiotic Therapy versus Immediate Prostate Biopsy
Avraham Shtricker et al.
INTERNATIONAL BRAZ J UROL (2009)
The Relationship between Prostate Inflammation and Lower Urinary Tract Symptoms: Examination of Baseline Data from the REDUCE Trial
J. Curtis Nickel et al.
EUROPEAN UROLOGY (2008)
Serum PSA and percent free PSA value changes after antibiotic treatment
Minoru Kobayashi et al.
UROLOGIA INTERNATIONALIS (2008)
PSA reduction (after antibiotics) permits to avoid or postpone prostate biopsy in selected patients
V. Serretta et al.
PROSTATE CANCER AND PROSTATIC DISEASES (2008)
Treatment of chronic bacterial prostatitis with levofloxacin and ciprofloxacin lowers serum prostate specific antigen
AJ Schaeffer et al.
JOURNAL OF UROLOGY (2005)
The impact of acute or chronic inflammation in baseline biopsy on the risk of clinical progression of BPH: Results from the MTOPS study
CG Roehrborn et al.
JOURNAL OF UROLOGY (2005)
Use of prostate-specific antigen (PSA) isoforms for the detection of prostate cancer in men with a PSA level of 2-10 ng/ml: Systematic review and meta-analysis
AW Roddam et al.
EUROPEAN UROLOGY (2005)
Meta-analysis of prostate-specific antigen and digital rectal examination as screening tests for prostate carcinoma
K Mistry et al.
JOURNAL OF THE AMERICAN BOARD OF FAMILY PRACTICE (2003)
Distribution of inflammation, pre-malignant lesions, incidental carcinoma in histologically confirmed benign prostatic hyperplasia: A retrospective analysis
F Di Silverio et al.
EUROPEAN UROLOGY (2003)
Effect of cernitin pollen-extract on experimental nonbacterial prostatitis in rats
T Kamijo et al.
PROSTATE (2001)
Consensus development of a histopathological classification system for chronic prostatic inflammation
JC Nickel et al.
BJU INTERNATIONAL (2001)
Prostate-specific antigen (PSA) value change after antibacterial therapy of prostate inflammation, as a diagnostic method for prostate cancer screening in cases of PSA value within 4-10 ng/ml and nonsuspicious results of digital rectal examination
G Karazanashvili et al.
EUROPEAN UROLOGY (2001)
Share Paper
